STEEMCC Initiative to Transform Care Coordination and Behavioral Health Access in the Virgin Islands
WASHINGTON, DC / ACCESS Newswire / August 4, 2025 / The St. Thomas East End Medical Center Corporation (STEEMCC) has...
Day: August 4, 2025
Duly Health and Care Opens New Multi-Specialty Clinic in Schaumburg
Expanding access to high-quality, physician-directed care in the northwest suburbs DOWNERS GROVE, IL / ACCESS Newswire / August 4, 2025...
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopePhase 1 study in adults with active and...
CarePayment Recognized as #1 Patient Financing Vendor in Black Book’s 2025 Revenue Cycle Management Rankings
TAMPA, FL / ACCESS Newswire / August 4, 2025 / CarePayment, a leading provider of patient financing solutions, has been...
Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given....
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
-Line has been in production at risk since early July- Production to continue until late August when conversion to Pivot...
Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program
70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss...
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline opportunitiesCAMBRIDGE, Mass., Aug. 04,...
Corporate Update, August 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank...
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council regionMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel,...
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency...
OneMedNet Reports Over 25% Expansion of iRWD™ Network, Encompassing Clinical Data alongside Aggregate Health Economics and Social Determinant Insights from 5 Billion Administrative Records, Fueling Growth in AI-Powered Healthcare Data
Over 1,750 provider sites and access to 136 million clinical exams positions OneMedNet for accelerated revenue and market penetrationMINNEAPOLIS, Aug....
Full Alliance Group Launches QUBEE HIVE HOLDINGS to Advance Global Web3 Financial Infrastructure
Strategic Infrastructure Development Positions Company for Global Fintech ExpansionTAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc....
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to...
MaxCyte Signs Platform License Agreement with Adicet Bio
MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of Adicet’s gamma delta T cell therapy gene edited programs...
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
CORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the...
Xenon to Report Q2 2025 Financial Results on August 11, 2025
VANCOUVER, British Columbia and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company...
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
BioAtla to Announce Second Quarter 2025 Financial Results and Provide Business Highlights on August 7, 2025
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the...
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,...